Torigen Pharmaceuticals
Farmington, US · Delaware corporation · 7 known investors
Find your way into Torigen Pharmaceuticals
165 people in our graph share verified history with the Torigen Pharmaceuticals team — schools, employers, funds. One of them is your warm intro.
Dan McMurtrieunlockedknows Ashley Kalinauskas · together at University of Notre Dame (overlapped)
×11knows the team · via University of Connecticut
Founders & leadership
AK
Ashley KalinauskasinFounder · Chief Executive OfficerAshley Kalinauskas holds a master's degree in cancer immunology and business from the University of Notre Dame and co-founded Torigen Pharmaceuticals, which develops personalized cancer vaccines for veterinary use, building on technology from her graduate research.30 Under 30 2020
MS
Mark SuckowNamed on SEC filing
BP
Brad PoffNamed on SEC filing
TD
Terry DewNamed on SEC filing
Investors · 7
Chloe CapitalIthaca · $100K – $250K
Connecticut InnovationsNew Haven · $500K – $2M
Emerald Development ManagersNew York
Launchpad Venture GroupBoston · $8M – $10M
__Twitter.png)
GaingelsreportedNew York · $200K – $500K
SoGal Venturesreported · 4 sourcesNew York · $50K – $500Kvia Elizabeth Galbut · board
The FundreportedAustin · $50K – $250K
Reported raises · per SEC filings
Form D private placements$10.9M disclosed across 4 of 5 rounds · 2019–2022
▶$4.6MraisedMay 2022 · 30 investors · PharmaceuticalsRule 506(b)
▶$4.6MraisedMay 2022 · 30 investors · Pharmaceuticals
Rule 506(b)Officers, directors & promoters on the filing
- Blake HawleyDirector
- Kevin CrowleyDirector
- John KallassyExecutive Officer
- Musan DuricDirector
- Ashley KalinauskasExecutive Officer, Director
- Elizabeth GalbutDirector
- Offering amount
- $10M
- Amount sold
- $4.6M
- First sale
- May 2022
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$1.2MraisedDec 2021 · 16 investors · PharmaceuticalsRule 506(b)
▶$1.2MraisedDec 2021 · 16 investors · Pharmaceuticals
Rule 506(b)Officers, directors & promoters on the filing
- Ashley KalinauskasExecutive Officer, Director
- Kevin CrowleyDirector
- Mark SuckowExecutive Officer, Director
- John KallassyExecutive Officer
- Blake HawleyDirector
- Elizabeth GalbutDirector
- Offering amount
- $1.5M
- Amount sold
- $1.2M
- First sale
- Nov 2021
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$3.3MraisedMar 2021 · 38 investors · PharmaceuticalsRule 506(b)
▶$3.3MraisedMar 2021 · 38 investors · Pharmaceuticals
Rule 506(b)Officers, directors & promoters on the filing
- Ashley KalinauskasExecutive Officer, Director
- Mark SuckowExecutive Officer, Director
- John KallassyExecutive Officer
- Elizabeth GalbutDirector
- Kevin CrowleyDirector
- Blake HawleyDirector
- Offering amount
- $3.5M
- Amount sold
- $3.3M
- First sale
- Jun 2020
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$1.8MraisedJan 2019 · 9 investors · PharmaceuticalsRule 506(b)
▶$1.8MraisedJan 2019 · 9 investors · Pharmaceuticals
Rule 506(b)Officers, directors & promoters on the filing
- Ashley KalinauskasExecutive Officer
- Mark SuckowExecutive Officer, Director
- Brad PoffExecutive Officer
- Terry DewExecutive Officer
- Offering amount
- $2M
- Amount sold
- $1.8M
- First sale
- Jan 2019
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Competitors · 3
by search overlapPetcure Oncology10 shared keywordsPetCure Oncology, founded in 2014, operates a network of veterinary cancer care centers offering stereotactic radiation therapy (SRS/SRT) and other cancer treatments for pets. It serves pet owners in the U.S. seeking advanced radiation oncology options for animals with cancer.
Vcahospitals9 shared keywordsVCA Animal Hospitals operates a national network of veterinary hospitals providing primary care, specialty care, emergency care, urgent care, and boarding services for pets. The company combines advanced medical technology and procedures with compassionate care for pet owners and their animals.
Wagwalking9 shared keywordsWag! is a marketplace that connects pet owners with local pet caregivers for services including dog walking, drop-in visits, pet sitting, and boarding. The platform vets caregivers through background checks and provides real-time updates and communication tools for pet owners to monitor their pets during service.
Companies competing with Torigen Pharmaceuticals for the same Google search keywords, organic and paid, via search-intersection analysis.
In the news
Frequently asked questions
- Who founded Torigen Pharmaceuticals?
- Torigen Pharmaceuticals was founded by Ashley Kalinauskas.
- Who are Torigen Pharmaceuticals's investors?
- Torigen Pharmaceuticals's investors include Chloe Capital, Connecticut Innovations, Emerald Development Managers, Launchpad Venture Group, Gaingels, SoGal Ventures, The Fund.
- How much funding has Torigen Pharmaceuticals raised?
- Torigen Pharmaceuticals has disclosed $10.9M raised across 4 of its 5 known rounds.
- Where is Torigen Pharmaceuticals headquartered?
- Torigen Pharmaceuticals is headquartered in Farmington, US.